Scientists will be better able to see how living cells function thanks to a new automated 3D microscope that allows observation without the use of stains or markers, says a Swiss company that has produced the device.
This content was published on
2 minutes
swissinfo.ch/mga
Nanolive, a spin-off company from Lausanne’s Federal Institute of Technology (EPFL), says its microscope can zoom in to individual organelles to a resolution of less than 200 nanometres. One nanometre is one billionth of a metre.
More importantly, the microscope’s rotational scanning constructs 3D holographic images that display organelles in colour. This does away with the need to apply markers that damage or destroy cells, meaning they can be observed for longer periods.
This will enable scientists to observe how “biological processes work, how organelles interact and how mitochondria form intricate networks”, a press release statesExternal link.
“This paves the way to important discoveries that until now have been insufficiently understood because of the lack of a reliable way to observe them.”
For example, it will be possible to better see how cells respond to drugs or genetic mutations.
NanoliveExternal link, which is headquartered at EPFL’s innovation park in western Switzerland, came out with its first products in 2015 and plans to hire 15 new staff this year.
“We want to support the study of how living cells and bacteria work, evolve and react, thus building a solid base for new drugs and therapies, in order to enable breakthrough researches,” the company states on its website.
Popular Stories
More
Multinational companies
Azeri fossil-fuel cash cow brings controversy to Switzerland
Is artificial intelligence an advantage or a disadvantage for workers?
What is your experience with AI at work? Have you already used it? Has it helped you work better? Or has it caused you more stress, more work or caused you to lose your job? Tell us about your experiences!
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
This content was published on
Researchers from the Blue Brain Project have unveiled their ‘Cell Atlas’, a 3D, interactive, constantly-evolving simulation of a mouse brain.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.